TP53 mutation and survival in chronic lymphocytic leukemia.

  • Thorsten Zenz
  • , Barbara Eichhorst
  • , Raymonde Busch
  • , Tina Denzel
  • , Sonja Häbe
  • , Dirk Winkler
  • , Andreas Bühler
  • , Jennifer Edelmann
  • , Manuela Bergmann
  • , Georg Hopfinger (Co-author)
  • , Manfred Hensel
  • , Michael Hallek
  • , Hartmut Döhner
  • , Stephan Stilgenbauer

    Research output: Contribution to journalOriginal Articlepeer-review

    479 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)4473-4479
    JournalJOURNAL OF CLINICAL ONCOLOGY
    Volume28
    Issue number29
    DOIs
    Publication statusPublished - 2010

    Keywords

    • FLUDARABINE PLUS CYCLOPHOSPHAMIDE
    • DRUG-RESISTANCE
    • GENOMIC ABERRATIONS
    • DISEASE PROGRESSION
    • 1ST-LINE THERAPY
    • CD38 EXPRESSION
    • GENE-MUTATIONS
    • P53 MUTATIONS
    • ALEMTUZUMAB
    • CLL

    Cite this